An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...

Corstasis to present pivotal trial data on Bumetanide Nasal Spray at AHA 2024, highlighting safety, and efficacy. #AHA2024.

Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...

Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...

ALK will also pay up to $320m in milestone payments to ARS in the deal, which sees the latter keep rights in the US, ...

COLLEGE STATION, Texas — November is National Alzheimer's Awareness Month and now a new therapy out of Texas A&M University could treat Alzheimer's disease through a nasal spray. Seven million ...

Once the nasal spray is absorbed through the membranes in the nose, it enters the bloodstream and works to stimulate melanin ...

TurboFil's fully automated UDS Vial Filling & Assembly System produces up to 100 unidose nasal spray devices per minute and ...

Students requested the vending machine with Narcan to be proactive and responsive to the city's opioid crisis, Penn officials ...

Commercial launch of neffy®(epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by ...

Common decongestants may soon be pulled from shelves. The Food and Drug Administration (FDA) announced Wednesday its proposal ...

Although ARS Pharmaceuticals’ approval for its epinephrine nasal spray came later than expected, the company ultimately received a thumbs up from the FDA in August and is now moving fast to expand ...